$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
$100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today
Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.44% on an annualized basis producing an average annual return of 14.87%. Currently, Biomarin Pharmaceutical has a market capitalization of $16.09 billion.
在过去的20年中，Biomarin Pharmaceutical（纳斯达克股票代码：BMRN）的年化表现比市场高6.44％，平均年回报率为14.87％。目前，Biomarin Pharmaceutical的市值为160.9亿美元。
Buying $100 In BMRN: If an investor had bought $100 of BMRN stock 20 years ago, it would be worth $1,718.66 today based on a price of $84.73 for BMRN at the time of writing.
购买100美元的BMRN股票：如果投资者在20年前购买了100美元的BMRN股票，那么按撰写本文时BMRN的84.73美元的价格计算，今天的价值将为1718.66美元。
Biomarin Pharmaceutical's Performance Over Last 20 Years
Biomarin Pharmaceutical在过去 20 年的表现
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
最后，这一切的意义何在？从本文中得出的关键见解是，在一段时间内，复合回报可以对您的现金增长产生多大的影响。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。